Returns Chart

Key Stats

Net Expense Ratio Total Assets Under Management Weighted Average Dividend Yield Turnover Ratio (Generic)
-- -- -- --
1 Year Fund Level Flows 1 Year Total Returns (Daily) Annualized Total Returns Since Inception (Daily) Max Drawdown (Since Inception)
-- -- Upgrade Upgrade

Basic Info

Investment Strategy
The Fund seeks capital appreciation together with current income. The Fund invests at least 80% of its assets in convertible securities like bonds, debentures, corporate notes, preferred stocks or other securities that are convertible to common stock or the cash value of a stock or a basket or index of equity securities.
General
Security Type Mutual Fund
Broad Asset Class Allocation
Broad Category Allocation
Global Peer Group Bond Convertibles US
Peer Group Convertible Securities Funds
Global Macro Bond Other
US Macro Mixed-Assets Funds
YCharts Categorization --
YCharts Benchmark --
Prospectus Objective Convertible Securities Funds
Fund Owner Firm Name New York Life Investments
Broad Asset Class Benchmark Index
^SPXTR 100.0%

View Basic Info
Start Trial

Net Fund Flows Versus Peer Group

View Net Fund Flows Versus Peer Group
Start Trial
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
 
80.00B
60.00B
40.00B
20.00B
0
-20.00B
No Data Available
1 Month
% Rank: --
-- Peer Group Low
-- Peer Group High
1 Year
% Rank: --
-- Peer Group Low
-- Peer Group High
3 Months
% Rank: --
-- Peer Group Low
-- Peer Group High
3 Years
% Rank: --
-- Peer Group Low
-- Peer Group High
6 Months
% Rank: --
-- Peer Group Low
-- Peer Group High
5 Years
% Rank: --
-- Peer Group Low
-- Peer Group High
YTD
% Rank: --
-- Peer Group Low
-- Peer Group High
10 Years
% Rank: --
-- Peer Group Low
-- Peer Group High
Date Unavailable

Performance Versus Peer Group

 
20%
15%
10%
5%
0
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (NAV)
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
Peer Group Rtn. (NAV)
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
% Rank in Peer Group (NAV)
5.0
5.0
5.0
5.0
5.0
5.0
5.0
5.0
View Performance Versus Peer Group
Start Trial

Annual Total Returns Versus Peers

Loading chart...
Name
2018
2019
2020
2021
2022
2023
2024
YTD
-3.43%
20.93%
33.74%
8.82%
-13.06%
7.75%
7.05%
-0.88%
-4.38%
31.49%
18.40%
28.71%
-18.11%
26.29%
25.02%
-1.55%
1.95%
25.16%
54.19%
4.21%
-19.45%
7.26%
12.99%
-1.71%
-0.26%
18.36%
47.27%
4.44%
-21.83%
9.79%
8.88%
-1.63%
-6.60%
12.17%
18.77%
3.42%
-11.44%
5.00%
4.68%
-0.08%
-4.20%
23.95%
62.93%
0.29%
-23.86%
6.40%
13.01%
0.14%
As of March 05, 2025.

Fundamentals

General
Distribution Yield --
Dividend Yield TTM --
30-Day SEC Yield --
7-Day SEC Yield --
Stock
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio --
Weighted Average Price to Book Ratio --
Weighted Median ROE --
Weighted Median ROA --
ROI (TTM) --
Return on Investment (TTM) --
Earning Yield --
LT Debt / Shareholders Equity --
Bond
Yield to Maturity --
Average Coupon --
Calculated Average Quality --
Effective Maturity --
Nominal Maturity --

Growth Metrics

EPS Growth (1Y) -0.08%
EPS Growth (3Y) 64.11%
EPS Growth (5Y) 5.53%
Sales Growth (1Y) 47.28%
Sales Growth (3Y) 44.98%
Sales Growth (5Y) 46.22%
Sales per Share Growth (1Y) 68.60%
Sales per Share Growth (3Y) 37.68%
Operating Cash Flow - Growth Ratge (3Y) -21.57%
As of December 31, 2024

Fund Details

Key Dates
Inception Date 5/1/1986
Last Annual Report Date 10/31/2024
Last Prospectus Date 2/28/2024
Share Classes
MCINX Inv
MCNVX Inst
MCOAX A
Attributes
Index Fund --
Inverse Fund --
Leveraged Fund --
Fund of Funds No
Currency Hedged Fund --
Synthetic Replication Fund No

Asset Allocation

As of December 31, 2024.
Type % Net
Cash 0.01%
Stock 1.80%
Bond 87.59%
Convertible 0.00%
Preferred 5.58%
Other 5.02%
View Asset Allocation
Start Trial

Top 10 Holdings

Name % Weight Price % Change
NYLI U.S. Government Liquidity Class I 6.05% 1.00 0.00%
NRG Energy Inc 2.75% 01-JUN-2048
2.21% -- --
Lantheus Holdings Inc 2.625% 15-DEC-2027
2.05% -- --
Merit Medical Systems Inc 3% 01-FEB-2029
2.05% -- --
Tetra Tech Inc 2.25% 15-AUG-2028
1.90% -- --
Integer Holdings Corp 2.125% 15-FEB-2028
1.87% -- --
Exact Sciences Corp 1.75% 15-APR-2031
1.83% -- --
Carnival Corp 5.75% 01-DEC-2027
1.81% -- --
Southwest Airlines Co 1.25% 01-MAY-2025
1.74% -- --
BioMarin Pharmaceutical Inc 1.25% 15-MAY-2027
1.71% -- --

Fees & Availability

Fees
Actual 12B-1 Fee 1.00%
Actual Management Fee 0.55%
Administration Fee --
Maximum Front Load --
Maximum Deferred Load 1.00%
Maximum Redemption Fee --
General Availability
Available for Insurance Product --
Available for RRSP --
Purchase Details
Open to New Investors Yes
Minimum Initial Investment 1000.00 None
Minimum Subsequent Investment 50.00 None

Basic Info

Investment Strategy
The Fund seeks capital appreciation together with current income. The Fund invests at least 80% of its assets in convertible securities like bonds, debentures, corporate notes, preferred stocks or other securities that are convertible to common stock or the cash value of a stock or a basket or index of equity securities.
General
Security Type Mutual Fund
Broad Asset Class Allocation
Broad Category Allocation
Global Peer Group Bond Convertibles US
Peer Group Convertible Securities Funds
Global Macro Bond Other
US Macro Mixed-Assets Funds
YCharts Categorization --
YCharts Benchmark --
Prospectus Objective Convertible Securities Funds
Fund Owner Firm Name New York Life Investments
Broad Asset Class Benchmark Index
^SPXTR 100.0%

View Basic Info
Start Trial

Fundamentals

General
Distribution Yield --
Dividend Yield TTM --
30-Day SEC Yield --
7-Day SEC Yield --
Stock
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio --
Weighted Average Price to Book Ratio --
Weighted Median ROE --
Weighted Median ROA --
ROI (TTM) --
Return on Investment (TTM) --
Earning Yield --
LT Debt / Shareholders Equity --
Bond
Yield to Maturity --
Average Coupon --
Calculated Average Quality --
Effective Maturity --
Nominal Maturity --

Growth Metrics

EPS Growth (1Y) -0.08%
EPS Growth (3Y) 64.11%
EPS Growth (5Y) 5.53%
Sales Growth (1Y) 47.28%
Sales Growth (3Y) 44.98%
Sales Growth (5Y) 46.22%
Sales per Share Growth (1Y) 68.60%
Sales per Share Growth (3Y) 37.68%
Operating Cash Flow - Growth Ratge (3Y) -21.57%
As of December 31, 2024

Fund Details

Key Dates
Inception Date 5/1/1986
Last Annual Report Date 10/31/2024
Last Prospectus Date 2/28/2024
Share Classes
MCINX Inv
MCNVX Inst
MCOAX A
Attributes
Index Fund --
Inverse Fund --
Leveraged Fund --
Fund of Funds No
Currency Hedged Fund --
Synthetic Replication Fund No

Top Portfolio Holders

Name % Weight
Portfolio A 5.00%
Portfolio B 3.50%
Portfolio C 2.25%
View Top Portfolio Holders
Start Trial

Excel Add-In Codes

Name: =YCI("M:MCCVX", "name")
Broad Asset Class: =YCI("M:MCCVX", "broad_asset_class")
Broad Category: =YCI("M:MCCVX", "broad_category_group")
Prospectus Objective: =YCI("M:MCCVX", "prospectus_objective")
To find the codes for any of our securities and financial metrics, see our Complete Excel Reference.
View Excel Add-In Codes
Start Trial